News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,706 Results
Type
Article (39689)
Company Profile (247)
Press Release (658770)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204169)
Career Advice (2007)
Deals (35419)
Drug Delivery (95)
Drug Development (81044)
Employer Resources (172)
FDA (16180)
Job Trends (14857)
News (345187)
Policy (32536)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49434)
ALS (88)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (124)
Approvals (16185)
Artificial intelligence (252)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2250)
Cardiovascular disease (173)
Career advice (1676)
Career pathing (30)
CAR-T (150)
Cell therapy (421)
Cervical cancer (19)
Clinical research (65978)
Collaboration (832)
Compensation (524)
Complete response letters (19)
COVID-19 (2588)
CRISPR (40)
C-suite (240)
Cystic fibrosis (100)
Data (2195)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (270)
Diagnostics (6368)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86591)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112367)
Executive appointments (722)
FDA (17426)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (104)
Generative AI (19)
Gene therapy (301)
GLP-1 (707)
Government (4415)
Grass and pollen (4)
Guidances (59)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2730)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16509)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (467)
Leadership (17)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (303)
MASH (66)
Medical device (13375)
Medtech (13380)
Mergers & acquisitions (19453)
Metabolic disorders (682)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1909)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (362)
Opinion (204)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57293)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20552)
Phase II (29054)
Phase III (21647)
Pipeline (1184)
Policy (138)
Postmarket research (2563)
Preclinical (8738)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22270)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (29)
Vaccines (685)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (166)
Last 7 days (853)
Last 30 days (2608)
Last 365 days (32804)
2025 (10581)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55711)
2020 (54084)
2019 (46538)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37554)
2014 (31320)
2013 (26356)
2012 (28575)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37834)
Australia (6184)
California (6098)
Canada (2008)
China (520)
Colorado (265)
Connecticut (272)
Delaware (146)
Europe (81231)
Florida (907)
Georgia (205)
Idaho (57)
Illinois (533)
India (25)
Indiana (306)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (886)
Massachusetts (4548)
Michigan (219)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1719)
New Mexico (28)
New York (1735)
North Carolina (963)
North Dakota (8)
Northern California (2666)
Ohio (203)
Oklahoma (14)
Oregon (34)
Pennsylvania (1371)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2287)
Tennessee (101)
Texas (903)
United States (23006)
Utah (180)
Virginia (144)
Washington D.C. (61)
Washington State (549)
West Virginia (3)
Wisconsin (54)
698,706 Results for "natera inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Natera to Report its First Quarter Results on May 8, 2025
May 1, 2025
·
1 min read
Press Releases
Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
April 23, 2025
·
3 min read
Press Releases
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
April 24, 2025
·
3 min read
Press Releases
Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
February 25, 2025
·
5 min read
Press Releases
Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD
March 5, 2025
·
2 min read
Press Releases
Natera Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
·
14 min read
Lone Star Bio
Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
Natera, Inc. today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).
May 23, 2024
·
1 min read
Press Releases
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
March 10, 2025
·
6 min read
Press Releases
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
February 18, 2025
·
1 min read
Lone Star Bio
Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications
Natera, Inc. today announced that it has passed a significant milestone with the publication of more than 200 peer-reviewed papers highlighting Natera’s technology in the scientific literature.
April 22, 2024
·
3 min read
1 of 69,871
Next
